Detalhe da pesquisa
1.
Novel Therapies Potentially Available for Pediatric B-Cell Non-Hodgkin Lymphoma.
J Natl Compr Canc Netw
; 18(8): 1125-1134, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32755987
2.
Novel targeted therapeutic agents for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma.
Br J Haematol
; 185(6): 1111-1124, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30701541
3.
Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo.
Blood
; 127(9): 1128-37, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26675347
4.
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.
Br J Haematol
; 179(5): 739-747, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29082519
5.
Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma.
Br J Haematol
; 173(4): 597-616, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27062282
6.
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20(+) rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia (pre-B-ALL): potential targeted therapy in patients with poor risk CD20(+) BL and pre-B-ALL.
Br J Haematol
; 171(5): 763-75, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26471982
7.
Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents.
Br J Haematol
; 169(4): 506-19, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25712263
8.
Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report.
Br J Haematol
; 170(3): 367-71, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25858645
9.
Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report.
Br J Haematol
; 162(5): 678-83, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23802659
10.
Ofatumumab: a novel, fully human anti-CD20 monoclonal antibody for the treatment of chronic lymphocytic leukemia.
Future Oncol
; 9(12): 1829-39, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24295413
11.
Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells.
Blood Cancer Discov
; 4(3): 208-227, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36723991
12.
Ofatumumab demonstrates activity against rituximab-sensitive and -resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B-cell lymphoma.
Br J Haematol
; 156(4): 490-8, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22150234
13.
Stated acceptance and behavioral responses of drivers towards innovative connected vehicle applications.
Accid Anal Prev
; 155: 106095, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33798797
14.
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium.
Cancer Discov
; 11(6): 1424-1439, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563661
15.
The SMAC mimetic LCL-161 displays antitumor activity in preclinical models of rituximab-resistant B-cell lymphoma.
Blood Adv
; 2(23): 3516-3525, 2018 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30530779
16.
Pre-clinical activity of targeting the PI3K/Akt/mTOR pathway in Burkitt lymphoma.
Oncotarget
; 9(31): 21820-21830, 2018 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29774105
17.
Pegaspargase hypersensitivity reactions: intravenous infusion versus intramuscular injection - a review.
Leuk Lymphoma
; 58(4): 766-772, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27643446
18.
A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatment.
Oncotarget
; 8(69): 113895-113909, 2017 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29371955
19.
Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.
Mol Cancer Ther
; 16(9): 1779-1790, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28619753
20.
A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome.
Blood Adv
; 6(10): 3189-3193, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35157770